14th December 2012: ClinTec International, a leading global clinical research organisation announces Dr Rabinder Buttar has received the Scottish Asian Business women of the year award thanks to the company’s on-going success. The Scottish Asian Business Awards honour the achievements, determination and hard work of Scottish Asian Entrepreneurs who have been the leaders and drivers of growth in their industry.
Chairperson and CEO of ClinTec International, Dr Rabinder Buttar, commented: “I am delighted to receive this award. It demonstrates the progress that ClinTec International has made since 2009 when opening its headquarters in Glasgow - growing in emerging economies and developing our CRO services portfolio. This progress is down to innovation and the commitment of our diligent employees. The accolade highlights the significant contribution Asian women are making to business in Scotland and overseas.”
Dr Buttar, founded the company in 1997 and has in the last 15 years grown the company’s operations across more than 40 countries worldwide. Dr Buttar’s business acumen has helped her identify opportunities in emerging markets, where ClinTec International has developed clinical trial capabilities of local stakeholders. ClinTec has become a truly global organisation and has increased its ability to provide full CRO services - strong leadership by Dr Buttar has been critical in bringing these developments to fruition.
ClinTec International today collaborates with 8 of the top 10 global pharma companies in implementing their drug development programs worldwide, while continuing to strengthen its relationship with biotechs, medical device and virtual pharma companies.
ClinTec International has attracted huge support from the Scottish government, the Scottish business sector and the wider community. This support has provided a strong foundation for the robust growth ClinTec International has seen and continues to attain. The award is the latest accolade for Dr Buttar and ClinTec International having previously won the Queen’s Award for Enterprise and the Ernst and Young Scottish entrepreneur of the year award.
About ClinTec International
ClinTec International is a global clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec International has a presence in over 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, the Middle East and Africa, Central and South Africa, Asia and the US.
In addition to ClinTec International’s extensive expertise in oncology, the organisation has also conducted over 400 clinical trials in other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers and clinical research associates. ClinTec International’s ‘fast, flexible and focused’ approach to clinical research ensures an added advantage to the drug development process. The organisation’s range of services includes Clinical Monitoring, Project Management, Regulatory Affairs, Medical Writing, Data Management, Biostatistics, Global Clinical Resourcing, Quality Assurance, Drug Development Consultancy and Clinical Training courses.
For further information please contact:
Bobby Bal, Senior Director Corporate Development, ClinTec International Headquarters: +44 (0) 141 226 1120 or bbal@clintec.com
For more information about ClinTec, please visit www.clintec.com
For media enquiries, please contact Tristan Jervis or Alex Heeley on +44 (0) 207 861 3838 or e-mail: t.jervis@defacto.com
